SEC Tracker
Get the app

Compass Therapeutics CMPX

OrbiMed Genesis Master Fund (Director) plans to sell 3,571,428 CMPX shares, about $5.7M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Apr 9, 2025
  2. Broker: Jefferies LLC
  3. Shares acquired by: Public Offering

All of OrbiMed Genesis Master Fund's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 3,571,428 shares at $1.59 on Apr 9, 2025 ยท Form 4

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Compass Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Ocugen OCGN public float $279M, Jun 30, 2025
  2. Abeona Therapeutics ABEO public float $273M, Jun 30, 2025
  3. Tonix Pharmaceuticals Holding TNXP public float $271M, Jun 30, 2025
  4. Vanda Pharmaceuticals VNDA public float $269M, Jun 30, 2025
  5. Standard Biotools LAB public float $291M, Jun 30, 2025